SCHEMBL6231653

SCHEMBL6231653

COC(=O)c1c(C(=O)Cl)nc2cc(Cl)ccc2c1O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.48
PLA2G2A P14555 4/20 0.45
KMT2A Q03164 1/20 0.42
POLB P06746 1/20 0.40
NR4A2 P43354 1/20 0.40
KMO O15229 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
CHEK1 O14757 1/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
ABL1 P00519 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
ATM Q13315 1/20 0.38
MAP2K4 P45985 1/20 0.38
PHLPP2 Q6ZVD8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5754093 0.92 EGFR (0.53) EGFRPLA2G2AKMT2APOLBNR4A2
SCHEMBL5755105 0.90 EGFR (0.48) EGFRPLA2G2AKMT2APOLBNR4A2
SCHEMBL27559336 0.84 EGFR (0.48) EGFRPLA2G2AKMT2APOLBKMO
SCHEMBL8571325 0.81 PLA2G2A (0.55) EGFRPLA2G2AKMT2APOLBNR4A2
SCHEMBL8574404 0.81 EGFR (0.55) EGFRPLA2G2AKMT2ANR4A2KMO
SCHEMBL27368475 0.81 EGFR (0.45) EGFRPLA2G2AKMT2APOLBNR4A2
SCHEMBL6231676 0.79 NQO2 (0.40) PLA2G2AKMT2APOLBKDM4EALDH1A1
SCHEMBL8572727 0.78 EGFR (0.53) EGFRPLA2G2AKMT2ANR4A2KMO
SCHEMBL8574096 0.77 KDM4E (0.49) EGFRKMT2ANR4A2RXFP1KDM4E
SCHEMBL8572146 0.76 KDM4E (0.45) EGFRKMT2APOLBRXFP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1004582-B1 Pyridazino quinoline compounds ASTRAZENECA AB (SE) 2005-05-18 EP disclosed
EP-0790996-B1 PYRIDAZINOQUINOLINE COMPOUNDS ASTRAZENECA AB (SE) 2002-03-27 EP disclosed
US-6232313-B1 TREATING STROKE OR EPILEPTIC CONVULSIONS ASSOCIATED WITH EXCESSIVE CALCIUM INFLUX IN THE BRAIN CAUSED BY EXCITATORY AMINO ACIDS ZENECA LIMITED (GB) 2001-05-15 US disclosed
US-6214826-B1 NERVOUS SYSTEM DISORDERS ZENECA LIMITED (GB) 2001-04-10 US disclosed
EP-0724583-B1 PYRIDAZINO QUINOLINE COMPOUNDS ASTRAZENECA AB (SE) 2000-12-13 EP disclosed
CN-1053189-C pyridazino quinoline compounds ZENECA LTD (GB) 2000-06-07 CN disclosed
EP-1004582-A2 Pyridazino quinoline compounds AstraZeneca UK Limited (GB) 2000-05-31 EP disclosed
US-5744471-A NERVOUS SYSTEM DISORDERS ZENECA LIMITED (GB) 1998-04-28 US disclosed
CN-1171787-A Pyridazinoquinoline compounds ZENECA LTD (GB) 1998-01-28 CN disclosed
EP-0790996-A1 PYRIDAZINOQUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1997-08-27 EP disclosed
CN-1138332-A Pyridazinoquinoline compounds ZENECA LTD (GB) 1996-12-18 CN disclosed
EP-0724583-A1 PYRIDAZINO QUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1996-08-07 EP disclosed
WO-1996015127-A1 PYRIDAZINOQUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1996-05-23 WO disclosed
WO-1995011244-A1 PYRIDAZINO QUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1995-04-27 WO disclosed